Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER & CBOAlto Neuroscience, Inc. (ANRO) · full profile →Form 4 · filed Jul 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 3, 2025Disposed to issuer(D)45K0
Jul 3, 2025Grant(A)45K45K
Jul 3, 2025Grant(A)34K34K
Jul 3, 2025Disposed to issuer(D)34K0
Jul 3, 2025Grant(A)202K202K
Jul 3, 2025Disposed to issuer(D)202K0
Jul 3, 2025Grant(A)90K90K
Jul 3, 2025Disposed to issuer(D)90K0
Jul 3, 2025Grant(A)135K135K
Jul 3, 2025Disposed to issuer(D)135K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999480-25-000062) within minutes of acceptance. Every field above traces to the original document. Verify it directly: